查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552456

全球止血剂（止血材料）市场：到2033年的机会与策略

Hemostats Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球止血剂（hemostat）市值为27.8087亿美元，直到2023年复合年增长率超过2.0%。

手术次数增加

外科手术的增加带动了业绩期间内止血剂（止血材料）市场的成长。止血剂产品对于心血管外科、整形外科、神经外科和一般外科等不同外科专业至关重要，对整体市场需求做出了重大贡献。各种外科手术的增加直接导致医疗保健环境中对止血剂（止血剂）的需求增加。例如，2022 年 2 月美国脸部整形与重建外科学会 (AAFPRS) 的一份报告发现，2021 年进行了 140 万个例外科和非外科手术，比 2020 年平均增加了 600 例。因此，外科手术的增加支持了止血剂（止血剂）市场的成长。

目录

第一章执行摘要

  • 止血剂（止血材料）-市场吸引力与宏观经济情势

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特点

  • 一般市场定义
  • 概述
  • 止血剂（止血材料）市场定义及细分
  • 市场区隔：按产品
    • 活性止血剂（止血材料）
    • 被动止血剂（止血材料）
    • 复方止血剂（止血材料）
    • 其他产品
  • 市场区隔：依格式
    • 基质型和凝胶型止血剂（止血材料）
    • 床单、垫片用止血剂（止血材料）
    • 海绵止血剂（止血材料）
    • 粉末止血剂
    • 其他形式
  • 市场区隔：按应用
    • 整形外科
    • 一般外科
    • 神经外科
    • 心血管外科
    • 重组手术
    • 妇科手术
    • 其他用途

第七章 主要市场趋势

  • 止血粉技术创新
  • 市场参与者之间的策略合作与伙伴关係
  • 针对困难出血情况的尖端止血解决方案

第八章止血剂市场：宏观经济情景

  • COVID-19的影响：止血剂（止血材料）市场
  • 乌克兰战争的影响：止血剂（止血剂）市场
  • 高通膨影响：止血剂（止血剂）市场

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 2018-2023年市场驱动因素
    • 2018-2023年市场限制因素
  • 市场成长预测，2023-2028，2033F
    • 2023-2028年市场驱动因素
    • 2023-2028年市场限制因素

第十章 全球止血剂（止血材料）市场：细分

  • 全球止血剂（止血材料）市场：依产品分類的表现与预测，2018-2023、2028F、2033F
  • 全球止血剂（止血剂）市场：依处方分類的表现与预测，2018-2023、2028F、2033F
  • 全球止血剂（止血材料）市场：按应用分類的表现和预测，2018-2023、2028F、2033F

第十一章止血剂（止血材料）市场：区域与国家分析

  • 全球止血剂（止血剂）市场：按地区分類的绩效与预测，2018-2023、2028F、2033F
  • 全球止血剂（止血材料）市场：依国家分類的表现与预测，2018-2023、2028F、2033F

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Stryker Corporation

第20章 竞争基准化分析

第 21 章竞争对手仪表板

第二十二章 重大併购

  • AA Medical Acquired Surgical Product Solutions（SPS）
  • Hemostasis LLC Acquired Fiagon Medical Technologies
  • Ethicon Acquired GATT Technologies BV
  • Baxter Acquired CryoLife
  • Teleflex Acquired Z-Medica

第23章机会与策略

  • 2028 年全球止血剂市场：提供新机会的国家
  • 2028 年全球止血剂市场：提供新机会的细分市场
  • 2028年全球止血剂（止血材料）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第24章 止血剂（止血材料）市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第25章附录

简介目录
Product Code: o&s1313

Hemostats are surgical devices used to control bleeding during surgical procedures, making them essential in the medical and healthcare industry. These devices work by promoting blood clotting at the site of a surgical incision, thereby preventing excessive blood loss and facilitating the healing process.

The hemostats market consists of sales, by entities (organizations, sole traders and partnerships), of hemostats tools or equipment that are utilized by surgeons and medical practitioners across a wide range of surgical fields, including but not limited to orthopedic, neurological, cardiovascular, reconstructive, gynecological and general surgeries, to reduce or suppress bleeding. They are often used in operating rooms, emergency rooms and other medical settings where bleeding control is critical.

The global hemostats market was valued at $2,780.87 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 2.0%.

Increase In Surgical Procedures

An increase in surgical procedures drove the growth of the hemostats market during the historic period. Hemostatic products are essential across diverse surgical specialties such as cardiovascular, orthopedic, neurosurgery and general surgery, contributing significantly to the overall market demand. The growth in these varied surgical procedures directly drives the increasing need for hemostats in healthcare settings. For instance, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) report in February 2022, 1.4 million surgical and non-surgical procedures were done in 2021, on an average of 600 more procedures had increased when compared with 2020. Therefore, an increase in surgical procedures supported the growth of the hemostats market.

Innovation In Hemostatic Powder Technology

Major companies operating in the hemostats market are focused on advancing their new technologies and research and developments. New product lines ensure that surgeons have access to the right tools for effectively controlling bleeding across a wide range of surgical procedures, thereby optimizing patient care. For instance, in March 2023, Baxter, a US-based healthcare company, launched PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready-to-use and designed for patients with intact coagulation to address mild bleeding. The launch of PERCLOT in the U.S. provides surgeons a full range of active and passive hemostatic products for bleeding control, helping to optimize care for their patients.

The global hemostats market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 60.22% of the total market in 2023.

Hemostats Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hemostats market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for hemostats? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider hemostats market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by formulation and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the hemostats market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by formulation and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for hemostats providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
  • 2) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats; Other Formulations
  • 3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
  • Companies Mentioned: Baxter International Inc.; B. Braun Melsungen AG; Integra LifeSciences Corporation; Johnson & Johnson Inc.; Stryker Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hemostats indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Hemostats - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Hemostats Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Active Hemostats
    • 6.4.2 Passive Hemostats
    • 6.4.3 Combination Hemostats
    • 6.4.4 Other Products
  • 6.5 Market Segmentation By Formulation
    • 6.5.1 Matrix And Gel Hemostats
    • 6.5.2 Sheet And Pad Hemostats
    • 6.5.3 Sponge Hemostats
    • 6.5.4 Powder Hemostats
    • 6.5.5 Other Formulations
  • 6.6 Market Segmentation By Application
    • 6.6.1 Orthopedic Surgery
    • 6.6.2 General Surgery
    • 6.6.3 Neurological Surgery
    • 6.6.4 Cardiovascular Surgery
    • 6.6.5 Reconstructive Surgery
    • 6.6.6 Gynecological Surgery
    • 6.6.7 Other Applications

7 Major Market Trends

  • 7.1 Innovation In Hemostatic Powder Technology
  • 7.2 Strategic Collaborations And Partnerships Among Market Players
  • 7.3 Cutting-Edge Hemostat Solutions For Challenging Bleeding Scenarios

8 Hemostats Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Hemostats Market
  • 8.2 Impact Of The War In Ukraine On The Hemostats Market
  • 8.3 Impact Of High Inflation On The Hemostats Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Hemostats Market Segmentation

  • 10.1 Global Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Hemostats Market, Regional and Country Analysis

  • 11.1 Global Hemostats Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Hemostats Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Hemostats Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Major Companies
  • 12.10 China Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Hemostats Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Hemostats Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Hemostats Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Regulations
    • 16.2.5 Regulatory Bodies
    • 16.2.6 Major Associations
    • 16.2.7 Taxes Levied
    • 16.2.8 Corporate Tax Structure
    • 16.2.9 Major Companies
  • 16.3 South America Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Hemostats Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Baxter International Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 B. Braun Melsungen AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Integra LifeSciences Corporation
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Johnson & Johnson
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Stryker Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 AA Medical Acquired Surgical Product Solutions (SPS)
  • 22.2 Hemostasis LLC Acquired Fiagon Medical Technologies
  • 22.3 Ethicon Acquired GATT Technologies B.V
  • 22.4 Baxter Acquired CryoLife
  • 22.5 Teleflex Acquired Z-Medica

23 Opportunities And Strategies

  • 23.1 Global Hemostats Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Hemostats Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Hemostats Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Hemostats Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer